✦ LIBER ✦

Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy

✍ Scribed by Kay E. Davies; Miranda D. Grounds

Book ID: 116890980
Publisher: Elsevier
Year: 2007
Tongue: English
Weight: 77 KB
Volume: 1
Category: Article
ISSN: 1934-5909
DOI: 10.1016/j.stem.2007.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mesenchymal stem cells as anti-inflammat

Mesenchymal stem cells as anti-inflammatories: Implications for treatment of Duchenne muscular dystrophy

✍ Thomas E. Ichim; Doru T. Alexandrescu; Fabio Solano; Fabian Lara; Rosalia De Nec 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 197 KB

“Should all eligible patients with multi

“Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?”

✍ Philippe Moreau; S. Vincent Rajkumar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Comparison of allogeneic stem cell trans

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as

Peripheral blood stem cell transplantati

Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?

✍ Vellenga, E; van Putten, W L J; Boogaerts, M A; Daenen, S M G J; Verhoef, G E G; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB

Reduced-intensity allogeneic stem cell t

Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT

✍ Dreger, P; Glass, B; Seyfarth, B; Humpe, A; Claviez, A; von Neuhoff, N; Suttorp, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Retrospective Review of Dpace Therapy as

Retrospective Review of Dpace Therapy as a Salvage Regimen in Patients with Relapsed Multiple Myeloma Prior to Autologous Stem Cell Transplant

✍ J.N. Snider; S.D. Stelts; M. Awan; M. Raza; S. Goorha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB